Jangee Flexibilis

Drospirenone/Ethinylestradiol, the active ingredient in Jangee Flexibilis, is a combined oral contraceptive presented as a combined oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Jangee Flexibilis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jangee Flexibilis, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.

- Contraception: provides reliable prevention of unintended pregnancy in women of childbearing potential. - Family planning: enables controlled timing of pregnancies for individuals and couples. - Birth control: reduces the risk of accidental conception during regular sexual activity.

Jangee Flexibilis may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: occasional stomach upset, especially when first starting therapy. - Headache: mild to moderate tension‑type headaches. - Breast tenderness: temporary swelling or discomfort of the breasts. - Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins, potentially life‑threatening. - Stroke: rare cerebrovascular event, more likely in high‑risk individuals. - Pulmonary embolism: clot migration to the lungs, requiring urgent care. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hyperkalemia: elevated potassium levels due to drospirenone’s antimineralocorticoid activity.

Before prescribing Jangee Flexibilis, clinicians should evaluate several safety considerations.

- Assess cardiovascular risk: review history of thromboembolic events or clotting disorders. - Screen for hypertension: monitor blood pressure regularly during treatment. - Check liver function: avoid use in severe hepatic impairment. - Avoid smoking: especially in women over 35 years of age. - Review concomitant medications: consider potential drug interactions. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Jangee Flexibilis can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce contraceptive efficacy. - Antifungal agents (e.g., itraconazole): can increase hormone levels, raising side‑effect risk. - Protease inhibitors (e.g., ritonavir): may affect hormone metabolism.

Moderate Interactions (Monitor Closely): - SSRIs (e.g., fluoxetine): may increase risk of mood changes. - Antihypertensives (e.g., spironolactone): additive effect on potassium balance. - St. John’s wort: herbal inducer that can lower contraceptive effectiveness.